Sort
50,496 grants matching “lung cancer”
Mechanisms of Biguanide Sensitivity in GBM
$504,183Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · NS
Molecular Diagnostics Core Laboratory
$504,147Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
RADIOPHARMACY AND ASSAYS
$504,135David Morris Colcher · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA
Christiana Care CCOP
$504,125Christiana Care Health Services, Inc. · U10 · FY2002 · CA
Role of IKK alpha in lung squamous cell carcinoma development
$504,123Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis
$504,123Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Evaluation of the Implementation and Effectiveness of the American College of Surgeons Operative Standards Program
$504,112Lesly A Dossett · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Development of a Perfusion-induced Systemic Hyperthermia Delivery Apparatus
$504,080Joseph B Zwischenberger · Exatherm, Inc. · R42 · FY2010 · CA
Gasdermin E and pyroptosis in cancer
$504,066Judy Lieberman · Boston Children'S Hospital · R01 · FY2020 · CA
Gasdermin E and pyroptosis in cancer
$504,066Judy Lieberman · Boston Children'S Hospital · R01 · FY2021 · CA
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
$504,040Noriyuki Kasahara · University Of Miami School Of Medicine · R01 · FY2017 · CA
Targeting epigenetic reader GAS41
$504,038Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Genetic Instability & Risk for Esophageal Carcinoma
$503,936Xifeng Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Regulatory immune cells in immune suppression: The role of tBregs
$503,916Arya Biragyn · National Institute On Aging · ZIA · FY2018 · AG
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
$503,782William Douglas Figg · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Simultaneous dose and dose rate optimization for clinical FLASH proton radiotherapy
$503,780Hao Gao · University Of Kansas Medical Center · R01 · FY2022 · CA
An Improved Red Blood Cell Storage Product and Extended Shelf Life using a Normoglycemic Additive Solution
$503,764Dana M Spence · Michigan State University · R01 · FY2022 · HL
An Improved Red Blood Cell Storage Product and Extended Shelf Life using a Normoglycemic Additive Solution
$503,764Dana M Spence · Michigan State University · R01 · FY2023 · HL
The Role of Protein Kinases in NRF2-driven Lung Squamous Cell Carcinoma
$503,737Michael Benjamin Major · Washington University · R01 · FY2021 · CA
Benzo[a]pyrene Micro-dosing of Humans: A New Tool for Exposure, Risk Assessment and Prevention
$503,711David E. Williams · Oregon State University · R01 · FY2019 · ES
Targeted Degradation of EGFR and HER2 in NSCLC
$503,685Yuesheng Zhang · Virginia Commonwealth University · R01 · FY2024 · CA
CAREER: MOEMS-based Head-mounted NIR-II Microscopy for Molecular Imaging of Brain Tumor in Freely Behaving Small Animal Models
$503,644Wen Li · Michigan State University · · FY2023 · ENG
Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes
$503,575A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Identifying and understanding drivers of chemoresistance in small cell lung cancer
$503,547David Macpherson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer
$503,540Alexander V Kabanov · Univ Of North Carolina Chapel Hill · U54 · FY2016 · CA